XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of selected financial data for reportable segments
The following tables summarize selected financial data for the Company’s reportable segments.
 Three Months Ended June 30,Six Months Ended June 30,
 2022202320222023
 (in thousands)
Revenue:    
Critical illness recovery hospital$545,908 $575,091 $1,147,663 $1,169,017 
Rehabilitation hospital228,887 240,856 449,521 472,318 
Outpatient rehabilitation287,258 302,972 559,198 598,875 
Concentra441,357 467,079 864,780 923,377 
Other81,331 88,530 163,126 175,921 
Total Company$1,584,741 $1,674,528 $3,184,288 $3,339,508 
Adjusted EBITDA:    
Critical illness recovery hospital$20,019 $65,496 $55,986 $142,269 
Rehabilitation hospital49,845 54,689 92,224 101,905 
Outpatient rehabilitation33,601 32,850 60,197 63,049 
Concentra92,607 100,391 182,076 194,139 
Other(1)
(15,078)(33,957)(45,642)(67,830)
Total Company$180,994 $219,469 $344,841 $433,532 
Total assets:    
Critical illness recovery hospital$2,387,516 $2,492,370 $2,387,516 $2,492,370 
Rehabilitation hospital1,194,739 1,209,737 1,194,739 1,209,737 
Outpatient rehabilitation1,360,600 1,399,782 1,360,600 1,399,782 
Concentra2,301,296 2,314,328 2,301,296 2,314,328 
Other307,507 285,652 307,507 285,652 
Total Company$7,551,658 $7,701,869 $7,551,658 $7,701,869 
Purchases of property, equipment, and other assets:    
Critical illness recovery hospital$19,528 $31,363 $39,097 $55,021 
Rehabilitation hospital4,821 1,903 11,095 10,485 
Outpatient rehabilitation9,314 10,476 18,728 20,408 
Concentra8,716 15,846 18,956 30,246 
Other3,953 (74)5,301 2,239 
Total Company$46,332 $59,514 $93,177 $118,399 
_______________________________________________________________________________
(1)    For the three and six months ended June 30, 2022, Adjusted EBITDA included other operating income of $15.1 million. The other operating income is related to the recognition of payments received under the Provider Relief Fund for health care related expenses and loss of revenue attributable to COVID-19.
Schedule of reconciliation of Adjusted EBITDA to income before income taxes
A reconciliation of Adjusted EBITDA to income before income taxes is as follows:
 Three Months Ended June 30, 2022
 Critical Illness Recovery HospitalRehabilitation HospitalOutpatient
Rehabilitation
ConcentraOtherTotal
 (in thousands)
Adjusted EBITDA$20,019 $49,845 $33,601 $92,607 $(15,078) 
Depreciation and amortization(14,603)(7,175)(8,130)(18,730)(2,443) 
Stock compensation expense— — — (536)(8,410) 
Income (loss) from operations$5,416 $42,670 $25,471 $73,341 $(25,931)$120,967 
Equity in earnings of unconsolidated subsidiaries    6,167 
Interest expense    (41,052)
Income before income taxes    $86,082 
 Three Months Ended June 30, 2023
 Critical Illness Recovery HospitalRehabilitation HospitalOutpatient
Rehabilitation
ConcentraOtherTotal
 (in thousands)
Adjusted EBITDA$65,496 $54,689 $32,850 $100,391 $(33,957) 
Depreciation and amortization(13,886)(6,887)(8,779)(18,283)(2,104) 
Stock compensation expense— — — — (10,326) 
Income (loss) from operations$51,610 $47,802 $24,071 $82,108 $(46,387)$159,204 
Equity in earnings of unconsolidated subsidiaries    10,501 
Interest expense    (48,997)
Income before income taxes    $120,708 

 Six Months Ended June 30, 2022
 Critical Illness Recovery HospitalRehabilitation HospitalOutpatient
Rehabilitation
ConcentraOtherTotal
 (in thousands)
Adjusted EBITDA$55,986 $92,224 $60,197 $182,076 $(45,642) 
Depreciation and amortization(29,221)(13,977)(16,159)(37,542)(5,221) 
Stock compensation expense— — — (1,071)(16,698) 
Income (loss) from operations$26,765 $78,247 $44,038 $143,463 $(67,561)$224,952 
Equity in earnings of unconsolidated subsidiaries    11,564 
Interest expense    (76,566)
Income before income taxes    $159,950 
 Six Months Ended June 30, 2023
 Critical Illness Recovery HospitalRehabilitation HospitalOutpatient
Rehabilitation
ConcentraOtherTotal
 (in thousands)
Adjusted EBITDA$142,269 $101,905 $63,049 $194,139 $(67,830) 
Depreciation and amortization(30,523)(13,775)(17,236)(36,593)(4,237) 
Stock compensation expense— — — (178)(20,329) 
Income (loss) from operations$111,746 $88,130 $45,813 $157,368 $(92,396)$310,661 
Equity in earnings of unconsolidated subsidiaries    19,057 
Interest expense    (97,568)
Income before income taxes    $232,150